This trial is evaluating whether Neurofeedback will improve 2 primary outcomes, 4 secondary outcomes, and 3 other outcomes in patients with Attention Deficit Hyperactivity Disorder (ADHD). Measurement will happen over the course of baseline and 6 weeks.
This trial requires 60 total participants across 3 different treatment groups
This trial involves 3 different treatments. Neurofeedback is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"There are many different treatments available for ADHD, including medication, speech therapy, occupational therapy, and psychotherapy. Treatment should be tailored to the specific needs of the patient and may vary according to the severity and the comorbidities of the disease. There is no single best treatment for ADHD. Treatment may vary for most and even a majority of the patients depending on the severity and co-morbidities of the disease." - Anonymous Online Contributor
"The symptoms of a diagnosis of ADHD may be expressed across many symptoms of comorbid disorders, including the signs of anxiety, mood, and behavioural problems. This adds to the complexity of distinguishing comorbid mood disorders, or psychiatric disorders that are comorbid with ADHD, such as eating disorders and/or somatoform disorders." - Anonymous Online Contributor
"ADHD affects 7% of adults and 3.1% of children. The percentage of people with ADHD seems to be stable over years. The prevalence of ADHD seems greatest in children and declines with age in adults." - Anonymous Online Contributor
"A diagnosis of AHD has an estimated prevalence of 0.5%-1% among students in primary school. A significant proportion of people with AHD do not have major psychiatric symptoms. Thus, AHD must be considered when estimating the prevalence of ADHD." - Anonymous Online Contributor
"Attention is a multisystem concept, having links with many physiological, psychological, and cognitive processes, which underlie normal behaviours. While it is not surprising that ADHD features are frequent in psychiatric disorders, many such disorders are also marked by the same symptom symptoms, and the clinical and cognitive features of ADHD are more similar to those of other disorders such as depression, schizophrenia, and ADHD is more accurately referred to as a syndrome and has been shown in numerous studies to be a continuum with the neurocognitive profiles of patients at risk for depression and ADHD. Attention deficiency is not an essential part of ADHD, but people with it struggle, often for decades, with everyday problems. In childhood and adulthood ADHD features are associated with a number of disorders." - Anonymous Online Contributor
"Adults with ADHD manifest many symptoms resembling ADHD in children. Adolescents with ADHD are similar to older children in age and gender, and they share the same symptoms in both genders." - Anonymous Online Contributor
"There is a growing number of clinical trials that are attempting to look at the effects of different options at treating ADHD. Attention deficit hyperactivity disorder research has been a growing target for researchers, and more research is needed to continue to help treat the symptoms of this disease." - Anonymous Online Contributor
"This article is an example of how neurofeedback has advanced the therapeutic applications of this technology and how the technology and methods for creating an experience have also progressed. Neurofeedback can be a useful tool for treating attention deficit hyperactivity disorder and may also help to reduce the debilitating symptoms of phantom limb syndrome." - Anonymous Online Contributor
"The present results suggest that children with adhd have deficits in attention, which are significant for all domains of cognitive performance. Attention skills are important in educational settings, and children with adhd may benefit from a comprehensive educational program." - Anonymous Online Contributor
"Although many studies have used the terms neurofeedback and neurotherapy, only three published studies have measured neurocognitive and psychophysiological response to this treatment method. Although the use of neurofeedback in a clinical setting is still evolving, the evidence, from these three studies, supports this method as a therapeutic tool for improving the well-being of patients." - Anonymous Online Contributor
"We found no difference in EEG or cognitive improvement between the active and the control group. This preliminary analysis was limited by two open uncontrolled studies with low sample size, lack of data on blinding or randomization procedures." - Anonymous Online Contributor
"The effects of an 8-week neurofeedback training program on the ADHD symptoms indicated that an additional treatment period of 2 months of neurofeedback can lead to improvements in patients' ADHD symptoms and quality of life." - Anonymous Online Contributor